Data search
Results for MligTC455_40961
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_40961 | 1390 | 28.96 | Mlig455_055735 | Neo: - Age: Down-Up-Up Region-specific R2: 4.023 Region-enriched R2: 3.902/0.00000 |
Mlig455_055735 {REF} {Length: 782} {Pfam: Pancreatic hormone peptide [PF00159.20, score=36.6]} {RNA1509_12482, RNA1509_45015, RNA1509_52082} {RNA1310_48462, RNA1509_12482, RNA1509_45015, RNA1509_52082} {RNA1509_12482, RNA1509_45015, RNA1509_52082, RNA815_25160} |
Cumulative graph for MligTC455_40961
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -0.968 | 5.085 | 0.39039 | 1.00000 | |
| RegionR2 | 3.902 | 5.085 | 0.00000 | 0.00000 | Specific for R2: 4.023 |
| RegionR3 | 1.699 | 5.085 | 0.00007 | 0.00333 | |
| RegionR4 | 0.144 | 5.085 | 0.78566 | 1.00000 | |
| RegionR5 | 0.051 | 5.085 | 0.90204 | 1.00000 | |
| RegionR6 | -0.689 | 5.085 | 0.19325 | 0.76070 | |
| RegionR7 | -2.077 | 5.085 | 0.00546 | 0.11681 | |
| RegionR8 | -2.062 | 5.085 | 0.02631 | 0.31655 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 1.248 | 5.085 | 0.31201 | 1.00000 | |
| RegenerationR2 | -1.451 | 5.085 | 0.00191 | 0.06666 | |
| RegenerationR3 | -1.152 | 5.085 | 0.01933 | 0.25488 | |
| RegenerationR4 | -0.924 | 5.085 | 0.08849 | 0.46683 | |
| RegenerationR5 | -1.488 | 5.085 | 0.00592 | 0.14128 | |
| RegenerationR6 | -1.438 | 5.085 | 0.02087 | 0.17918 | |
| RegenerationBL | 0.573 | 5.085 | 0.40182 | 0.77072 | |
| RegenerationTP | 0.983 | 5.085 | 0.21920 | 0.66235 |
Genes with expression patterns similar to MligTC455_40961
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_40961 | 1390 | 28.96 | Mlig455_055735 | Neo: - Age: Down-Up-Up Region-specific R2: 4.023 Region-enriched R2: 3.902/0.00000 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_055735 {REF} {Length: 782} {Pfam: Pancreatic hormone peptide [PF00159.20, score=36.6]} {RNA1509_12482, RNA1509_45015, RNA1509_52082} {RNA1310_48462, RNA1509_12482, RNA1509_45015, RNA1509_52082} {RNA1509_12482, RNA1509_45015, RNA1509_52082, RNA815_25160} | |
| 2. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 5.337 | 0.927 | 0.888 | 0.887 | 0.858 | 0.813 | 0.964 | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
| 3. | MligTC455_50347 | 549 | 11.43 | Mlig455_012382 | Neo: - Age: Down-Up-Up Region-specific R2: 6.390 Region-enriched R2: 6.623/0.00000 |
5.323 | 0.863 | 0.888 | 0.952 | 0.779 | 0.925 | 0.916 | Mlig455_012382 {REF} {Length: 797} {RNA1509_48155} {RNA1310_70969.2, RNA1509_48155} {RNA1509_48155, RNA815_39712} | |
| 4. | MligTC455_43602 | 1418 | 29.54 | Mlig455_053986 | Neo: - Age: - Region-specific R2: 4.626 Region-enriched R2: 3.844/0.00000 Regeneration-downregulated R2: -2.432 Regeneration-depleted R2: -2.432 |
5.272 | 0.804 | 0.962 | 0.901 | 0.888 | 0.810 | 0.907 | Mlig455_053986 {REF} {Length: 2161} {RNA1509_15576} {RNA1310_12096.1} {RNA815_32931} | |
| 5. | MligTC455_19875 | 82 | 1.71 | Mlig455_024408 | Neo: - Age: Down-Up-Down |
5.222 | 0.835 | 0.921 | 0.879 | 0.859 | 0.761 | 0.967 | Mlig455_024408 {REF} {Length: 2479} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_4968.1} {RNA815_23744} | |
| 6. | MligTC455_41130 | 1186 | 24.72 | Mlig455_000166, Mlig455_000179, Mlig455_067712 | Neo: - Age: Down-Up-Down Region-specific R2: 5.626 Region-enriched R2: 4.906/0.00009 Regeneration-downregulated R3: -5.200 Regeneration-depleted R3: -5.200 |
5.217 | 0.814 | 0.968 | 0.906 | 0.884 | 0.716 | 0.929 | Mlig455_000166 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_000179 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_067712 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} |
|
| 7. | MligTC455_44025 | 591 | 12.31 | Mlig455_050980 | Neo: - Age: - Region-specific R2: 5.366 Region-enriched R2: 5.986/0.00000 |
5.213 | 0.976 | 0.930 | 0.915 | 0.852 | 0.786 | 0.754 | Mlig455_050980 {REF} {Length: 587} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=49.7, Expect=7e-09]} {RNA1509_52032} {RNA1310_52449.2} {RNA815_56904} | |
| 8. | MligTC455_44525 | 3358 | 69.96 | Mlig455_004678, Mlig455_004741, Mlig455_004755, Mlig455_004840 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.742 Region-enriched R2: 10.296/0.00000 |
5.133 | 0.729 | 0.821 | 0.955 | 0.834 | 0.851 | 0.943 | Mlig455_004678 {REF} {Length: 845} {RNA1509_25712} {RNA1310_68954.2} {RNA815_35323} Mlig455_004741 {REF} {Length: 961} {RNA1509_25712} {RNA1310_68954.1} {RNA815_35323} Mlig455_004755 {REF} {Length: 1059} {RNA1509_25712} {RNA1310_68954.2} {RNA815_35323} Mlig455_004840 {REF} {Length: 918} {RNA1509_25712, RNA1509_29691} {RNA1310_68954.2, RNA1509_25712, RNA1509_29691} {RNA1509_25712, RNA1509_29691, RNA815_35323} |
|
| 9. | MligTC455_25915 | 4499 | 93.72 | Mlig455_005297 | Neo: - Age: - Region-enriched R2: 1.495/0.00336 Regeneration-downregulated BL: -1.833 Regeneration-depleted BL: -1.833 |
CPE | 5.049 | 0.744 | 0.842 | 0.857 | 0.956 | 0.827 | 0.823 | Mlig455_005297 {REF} {Length: 3239} {Pfam: Zinc carboxypeptidase [PF00246.26, score=188.0]; Carboxypeptidase regulatory-like domain [PF13620.8, score=23.3]} {Human: ENSG00000109472, CPE, carboxypeptidase E, [Score=322, Expect=8e-105]} {Mouse: ENSMUSG00000037852, Cpe, carboxypeptidase E, [Score=318, Expect=1e-103]} {Dmel: FBgn0004648, svr, silver, [Score=225, Expect=2e-68]} {Celegans: WBGene00001189, egl-21, Carboxypeptidase E, [RH, Score=333, Expect=5e-110]} {Smed: dd_Smed_v6_3059_0_1, dd_Smed_v6_3059_0_1, [RH, Score=384, Expect=7e-130]} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1310_4621.1, RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908, RNA815_1336.1} |
| 10. | MligTC455_25914 | 4684 | 97.58 | Mlig455_004975 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.418 Region-enriched R2: 1.471/0.00163 Regeneration-downregulated BL: -1.843 Regeneration-depleted BL: -1.843 |
5.016 | 0.721 | 0.836 | 0.871 | 0.951 | 0.821 | 0.816 | Mlig455_004975 {REF} {Length: 5220} {RNA1509_1158, RNA1509_11723} {RNA1310_4621.1, RNA1509_11723} {RNA1509_11723, RNA815_1336.1} | |
| 11. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 4.999 | 0.721 | 0.777 | 0.877 | 0.919 | 0.742 | 0.963 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
| 12. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
4.988 | 0.798 | 0.842 | 0.895 | 0.765 | 0.730 | 0.958 | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
| 13. | MligTC455_48848 | 282 | 5.87 | Mlig455_005151, Mlig455_021613 | Neo: - Age: - Region-specific R2: 4.764 Region-enriched R2: 5.813/0.00000 |
SYT3 | 4.629 | - | 0.911 | 0.951 | 0.877 | 0.945 | 0.945 | Mlig455_005151 {REF} {Length: 1574} {Pfam: C2 domain [PF00168.32, score=55.1]} {Human: ENSG00000213023, SYT3, synaptotagmin 3, [Score=68.6, Expect=5e-12]; ENSG00000011347, SYT7, synaptotagmin 7, [Score=67.0, Expect=1e-11]} {Mouse: ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=69.3, Expect=2e-12]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=63.2, Expect=1e-10]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=66.6, Expect=5e-12]} {Smed: dd_Smed_v6_25279_0_1, dd_Smed_v6_25279_0_1, [Score=85.1, Expect=2e-18]} {RNA1310_20857} {RNA815_8396} Mlig455_021613 {REF} {Length: 1574} {Pfam: C2 domain [PF00168.32, score=55.1]} {Human: ENSG00000213023, SYT3, synaptotagmin 3, [Score=68.6, Expect=5e-12]; ENSG00000011347, SYT7, synaptotagmin 7, [Score=67.0, Expect=1e-11]} {Mouse: ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=69.3, Expect=2e-12]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=63.2, Expect=1e-10]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=66.6, Expect=5e-12]} {Smed: dd_Smed_v6_25279_0_1, dd_Smed_v6_25279_0_1, [Score=85.1, Expect=2e-18]} {RNA1310_20857} {RNA815_8396} |
| 14. | MligTC455_46924 | 1562 | 32.53 | Mlig455_042561 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.240 Region-enriched R2: 5.226/0.00021 |
PI16 | 4.54 | - | 0.916 | 0.842 | 0.946 | 0.877 | 0.959 | Mlig455_042561 {REF} {Length: 1929} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=59.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=75.5, Expect=4e-14]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=78.6, Expect=3e-15]; ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=75.1, Expect=5e-15]} {Dmel: FBgn0038126, CG8483, [Score=65.9, Expect=2e-11]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.9, Expect=7e-12]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=140, Expect=2e-36]} {RNA1509_33691, RNA1509_4403} {RNA1310_19427.1, RNA1509_33691, RNA1509_4403} {RNA1509_33691, RNA1509_4403, RNA815_7689.1} |
| 15. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
4.537 | 0.968 | 0.950 | 0.890 | 0.796 | - | 0.933 | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
| 16. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
4.492 | 0.964 | - | 0.916 | 0.946 | 0.757 | 0.909 | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
| 17. | MligTC455_28560 | 6060 | 126.24 | Mlig455_028251 | Neo: - Age: - Region-specific R2: 2.839 Region-enriched R2: 1.867/0.00000 Regeneration-depleted BL: -1.887 |
SYT11 | 4.482 | - | 0.953 | 0.920 | 0.828 | 0.880 | 0.901 | Mlig455_028251 {REF} {Length: 2851} {Pfam: C2 domain [PF00168.32, score=161.3]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=304, Expect=1e-99]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=305, Expect=3e-100]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=353, Expect=3e-118]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=233, Expect=4e-73]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [RH, Score=397, Expect=6e-137]} {RNA1509_17703, RNA1509_303, RNA1509_58747} {RNA1310_7615, RNA1509_17703, RNA1509_58747} {RNA1509_17703, RNA1509_58747, RNA815_4825} |
| 18. | MligTC455_28559 | 6127 | 127.65 | Mlig455_028180 | Neo: - Age: - Region-specific R2: 2.829 Region-enriched R2: 1.854/0.00000 Regeneration-depleted BL: -1.839 |
SYT11 | 4.48 | - | 0.953 | 0.922 | 0.826 | 0.877 | 0.902 | Mlig455_028180 {REF} {Length: 2785} {Pfam: C2 domain [PF00168.32, score=161.4]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=305, Expect=7e-100]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=306, Expect=2e-100]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=351, Expect=1e-117]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=232, Expect=2e-72]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [RH, Score=399, Expect=2e-137]} {RNA1509_303} {RNA1310_7615, RNA1509_303} {RNA1509_303, RNA815_4825} |
| 19. | MligTC455_44904 | 1501 | 31.27 | Mlig455_021814 | Neo: - Age: Down-Up-Up Region-specific R2: 3.865 Region-enriched R2: 3.792/0.00000 |
4.474 | - | 0.912 | 0.855 | 0.930 | 0.818 | 0.959 | Mlig455_021814 {REF} {Length: 959} {RNA1509_15805} {RNA1310_67099.1, RNA1509_15805} {RNA1509_15805, RNA815_17533} | |
| 20. | MligTC455_50363 | 942 | 19.62 | Mlig455_012474 | Neo: - Age: Down-Up-Up Region-specific R2: 4.264 Region-enriched R2: 3.827/0.00000 |
4.472 | 0.831 | 0.934 | 0.836 | 0.968 | 0.903 | - | Mlig455_012474 {REF} {Length: 886} {RNA1509_58656} {RNA1310_57201.1} {RNA815_30531.1} | |
| 21. | MligTC455_19276 | 1694 | 35.28 | Mlig455_057303 | Neo: - Age: Down-Down-Up Region-specific R2: 5.711 Region-enriched R2: 6.117/0.00000 |
4.466 | 0.845 | 0.977 | 0.916 | 0.777 | - | 0.951 | Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171} | |
| 22. | MligTC455_44050 | 2086 | 43.46 | Mlig455_028045, Mlig455_028051 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.242 Region-specific R2: 6.161 Region-enriched R2: 7.072/0.00000 |
4.455 | 0.870 | 0.989 | 0.967 | - | 0.799 | 0.830 | Mlig455_028045 {REF} {Length: 1156} {RNA1509_31459, RNA1509_3903} {RNA1310_2730.2, RNA1509_31459, RNA1509_3903} {RNA1509_31459, RNA1509_3903, RNA815_7682} Mlig455_028051 {REF} {Length: 871} {NoTransDecoderORF} {RNA1509_3903} {RNA1310_15260} {RNA815_7682} |
|
| 23. | MligTC455_19277 | 1013 | 21.11 | Mlig455_059600 | Neo: - Age: - Region-specific R2: 4.883 Region-enriched R2: 5.766/0.00000 |
4.454 | 0.791 | 0.978 | 0.959 | 0.775 | - | 0.951 | Mlig455_059600 {REF} {Length: 827} {NoTransDecoderORF} {RNA1509_43907} {RNA1310_81348} | |
| 24. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
4.443 | - | 0.946 | 0.923 | 0.768 | 0.846 | 0.960 | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
| 25. | MligTC455_19278 | 4335 | 90.31 | Mlig455_057304, Mlig455_070944 | Neo: - Age: logFC(26M/2M)=0.686 Region-specific R2: 5.590 Region-enriched R2: 5.465/0.00000 |
CHRNA10 | 4.427 | 0.844 | 0.971 | 0.867 | 0.792 | - | 0.953 | Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1} |
| 26. | MligTC455_53239 | 733 | 15.27 | Mlig455_025537 | Neo: - Age: - Region-specific R2: 4.434 Region-enriched R2: 3.108/0.00000 |
4.389 | - | 0.956 | 0.846 | 0.868 | 0.810 | 0.909 | Mlig455_025537 {REF} {Length: 964} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=70.9, Expect=5e-15]} {Celegans: WBGene00010290, F58H1.7, [Score=63.9, Expect=8e-13]} {Smed: dd_Smed_v6_5576_0_1, dd_Smed_v6_5576_0_1, [RH, Score=168, Expect=2e-53]} {RNA1509_58542} {RNA1310_40950} {RNA815_19778.1} | |
| 27. | MligTC455_45134 | 9943 | 207.14 | Mlig455_022505 | Neo: - Age: - Region-enriched R2: 1.329/0.00560 Regeneration-downregulated BL: -1.932 Regeneration-depleted BL: -1.932 |
PAM | 4.381 | - | 0.894 | 0.785 | 0.975 | 0.900 | 0.827 | Mlig455_022505 {REF} {Length: 1757} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=107.0]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=69.2]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=190, Expect=4e-54]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=186, Expect=7e-53]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [Score=219, Expect=5e-69]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [Score=224, Expect=8e-72]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [Score=255, Expect=4e-83]} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1310_15063.1, RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118, RNA815_4981} |
| 28. | MligTC455_50348 | 34 | 0.7 | Mlig455_012803 | Neo: - Age: - |
4.379 | 0.916 | 0.854 | 0.879 | 0.774 | - | 0.956 | Mlig455_012803 {REF} {Length: 488} {RNA1509_48155} {RNA1310_70969.2} {RNA815_39712} | |
| 29. | MligTC455_47393 | 241 | 5.03 | Mlig455_008718, Mlig455_063579 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.683/0.00849 |
CALM2 | 4.378 | 0.857 | 0.831 | - | 0.891 | 0.834 | 0.965 | Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211} Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211} |
| 30. | MligTC455_14898 | 41 | 0.86 | Mlig455_011988 | Neo: - Age: - |
4.356 | 0.976 | - | 0.875 | 0.837 | 0.740 | 0.928 | Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
| 31. | MligTC455_45020 | 386 | 8.05 | Mlig455_012422 | Neo: - Age: - Region-enriched R2: 4.067/0.00066 |
AVP | 4.356 | - | 0.836 | 0.872 | 0.844 | 0.854 | 0.950 | Mlig455_012422 {REF} {Length: 1252} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.0]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=50.4, Expect=4e-08]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=52.0, Expect=7e-09]} {RNA1509_50574} {RNA1310_26737, RNA1509_50574} {RNA1509_50574, RNA815_23813} |
| 32. | MligTC455_45135 | 20518 | 427.46 | Mlig455_055032, Mlig455_055049 | Neo: - Age: - Region-enriched R2: 1.186/0.02756 Regeneration-downregulated BL: -2.004 Regeneration-depleted BL: -2.004 |
PAM | 4.351 | - | 0.885 | 0.759 | 0.972 | 0.903 | 0.832 | Mlig455_055032 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.5]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.9]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=205, Expect=4e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=4e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=232, Expect=1e-72]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_979} {RNA1310_15063.1} {RNA815_4981} Mlig455_055049 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.4]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.8]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=205, Expect=3e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=5e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=233, Expect=5e-73]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_32895, RNA1509_979} {RNA1310_15063.1, RNA1509_32895, RNA1509_979} {RNA1509_32895, RNA1509_979, RNA815_4981} |
| 33. | MligTC455_14685 | 3975 | 82.82 | Mlig455_051429 | Neo: - Age: - Region-specific R2: 2.895 Region-enriched R2: 2.262/0.00004 |
PAM | 4.342 | - | 0.961 | 0.812 | 0.902 | 0.921 | 0.746 | Mlig455_051429 {REF} {Length: 1911} {Pfam: NHL repeat [PF01436.23, score=59.1]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=119, Expect=2e-28]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=115, Expect=2e-27]} {Dmel: FBgn0262728, Pal2, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase 2, [Score=115, Expect=2e-28]} {Celegans: WBGene00017671, pgal-1, Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1, [Score=125, Expect=2e-32]} {Smed: dd_Smed_v6_3093_0_1, dd_Smed_v6_3093_0_1, [Score=138, Expect=4e-37]} {RNA1509_910} {RNA1310_18216.1} {RNA815_736.1} |
| 34. | MligTC455_47716 | 1445 | 30.1 | Mlig455_062374, Mlig455_062397 | Neo: - Age: Down-Up-Up Region-specific R2: 4.444 Region-enriched R2: 3.549/0.00000 |
4.335 | - | 0.953 | 0.810 | 0.798 | 0.873 | 0.901 | Mlig455_062374 {REF} {Length: 899} {RNA1509_16194} {RNA1310_50819.1} {RNA815_25538} Mlig455_062397 {REF} {Length: 907} {RNA1509_16194} {RNA1310_50819.1, RNA1509_16194} {RNA1509_16194, RNA815_25538} |
|
| 35. | MligTC455_41644 | 1214 | 25.28 | Mlig455_036599, Mlig455_057748, Mlig455_057750 | Neo: - Age: - Region-specific R2: 4.114 Region-enriched R2: 2.969/0.00052 Regeneration-downregulated BL: -8.163 Regeneration-depleted BL: -8.163 |
4.327 | - | 0.957 | 0.818 | 0.818 | 0.897 | 0.837 | Mlig455_036599 {REF} {Length: 673} {RNA1509_43529} {RNA1310_60851, RNA1509_43529} {RNA1509_43529, RNA815_37406} Mlig455_057748 {REF} {Length: 702} {RNA1509_43529} {RNA1310_60851} {RNA815_37406} Mlig455_057750 {REF} {Length: 401} {RNA1509_43529} {RNA1310_60851} {RNA815_37406} |
|
| 36. | MligTC455_45913 | 4034 | 84.05 | Mlig455_017927 | Neo: - Age: Down-Up-Up Region-specific R2: 3.031 Region-enriched R2: 2.341/0.00000 Regeneration-downregulated BL: -1.976 Regeneration-depleted BL: -1.976 |
4.324 | - | 0.955 | 0.901 | 0.911 | 0.849 | 0.708 | Mlig455_017927 {REF} {Length: 1006} {RNA1509_22540, RNA1509_32903, RNA1509_3805} {RNA1310_38334, RNA1509_22540, RNA1509_32903, RNA1509_3805} {RNA1509_22540, RNA1509_32903, RNA1509_3805, RNA815_18393} | |
| 37. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
4.311 | 0.962 | - | 0.918 | 0.734 | 0.757 | 0.940 | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
| 38. | MligTC455_16847 | 1240 | 25.83 | Mlig455_051898, Mlig455_053146 | Neo: - Age: Down-Up-Down Region-specific R2: 5.478 Region-enriched R2: 5.690/0.00000 |
PRSS33 | 4.307 | - | 0.893 | 0.952 | 0.783 | 0.800 | 0.879 | Mlig455_051898 {REF} {Length: 1360} {Pfam: Trypsin [PF00089.28, score=189.8]; Domain of unknown function (DUF1986) [PF09342.13, score=27.3]; Trypsin-like peptidase domain [PF13365.8, score=26.9]} {Human: ENSG00000103355, PRSS33, serine protease 33, [Score=159, Expect=4e-46]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=153, Expect=9e-41]; ENSMUSG00000037129, Tmprss13, transmembrane protease, serine 13, [Score=150, Expect=2e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=148, Expect=6e-39]; ENSMUSG00000022857, Tmprss15, transmembrane protease, serine 15, [Score=147, Expect=2e-38]} {Dmel: FBgn0036287, CG10663, [Score=146, Expect=1e-38]} {Celegans: WBGene00006620, svh-1, HGF/MSP/plasminogen-like protein, [Score=124, Expect=6e-31]} {Smed: dd_Smed_v6_10267_0_1, dd_Smed_v6_10267_0_1, [Score=178, Expect=4e-53]} {RNA1509_29335} {RNA1310_23561} {RNA815_9840} Mlig455_053146 {REF} {Length: 1448} {Pfam: Trypsin [PF00089.28, score=189.8]; Domain of unknown function (DUF1986) [PF09342.13, score=27.3]; Trypsin-like peptidase domain [PF13365.8, score=26.9]} {Human: ENSG00000103355, PRSS33, serine protease 33, [Score=159, Expect=4e-46]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=153, Expect=9e-41]; ENSMUSG00000037129, Tmprss13, transmembrane protease, serine 13, [Score=150, Expect=2e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=148, Expect=6e-39]; ENSMUSG00000022857, Tmprss15, transmembrane protease, serine 15, [Score=147, Expect=2e-38]} {Dmel: FBgn0036287, CG10663, [Score=146, Expect=1e-38]} {Celegans: WBGene00006620, svh-1, HGF/MSP/plasminogen-like protein, [Score=124, Expect=6e-31]} {Smed: dd_Smed_v6_10267_0_1, dd_Smed_v6_10267_0_1, [Score=178, Expect=4e-53]} {RNA1509_26566, RNA1509_29335} {RNA1310_23561, RNA1509_26566, RNA1509_29335} {RNA1509_26566, RNA1509_29335, RNA815_9840} |
| 39. | MligTC455_19876 | 135 | 2.82 | Mlig455_024520, Mlig455_024523 | Neo: - Age: - |
4.307 | - | 0.841 | 0.880 | 0.832 | 0.792 | 0.962 | Mlig455_024520 {REF} {Length: 2352} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} Mlig455_024523 {REF} {Length: 2311} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=153, Expect=3e-47]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} |
|
| 40. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 4.303 | 0.977 | - | 0.852 | 0.782 | 0.748 | 0.944 | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
| 41. | MligTC455_14831 | 280 | 5.83 | Mlig455_067864 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.261/0.00352 |
SSUH2 | 4.283 | - | 0.728 | 0.965 | 0.734 | 0.932 | 0.924 | Mlig455_067864 {REF} {Length: 1575} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=6e-54]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=7e-41]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=118, Expect=1e-29]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
| 42. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
4.263 | 0.792 | - | 0.952 | 0.807 | 0.764 | 0.948 | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
| 43. | MligTC455_45503 | 484 | 10.08 | Mlig455_068608 | Neo: - Age: logFC(26M/2M)=-0.477 Region-specific R2: 4.411 Region-enriched R2: 3.889/0.00000 |
4.261 | - | 0.924 | 0.953 | 0.773 | 0.709 | 0.902 | Mlig455_068608 {REF} {Length: 615} {RNA1509_28245, RNA1509_36616} {RNA1310_69460, RNA1509_28245, RNA1509_36616} {RNA1509_28245, RNA1509_36616, RNA815_56771} | |
| 44. | MligTC455_53581 | 10826 | 225.54 | Mlig455_061865 | Neo: - Age: Down-Down-Up Region-specific R2: 2.296 Region-enriched R2: 1.603/0.00040 Regeneration-downregulated BL: -1.690 Regeneration-depleted BL: -1.690 |
4.244 | - | 0.955 | 0.743 | 0.902 | 0.847 | 0.797 | Mlig455_061865 {REF} {Length: 1605} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=82.0]} {Dmel: FBgn0041707, 7B2, [RH, Score=70.1, Expect=1e-13]} {Celegans: WBGene00011392, sbt-1, Seven B Two (Mammalian 7BT prohormone convertase chaperone) homolog, [RH, Score=67.4, Expect=4e-13]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [RH, Score=118, Expect=1e-31]} {RNA1509_1202, RNA1509_24767} {RNA1310_24594, RNA1509_24767} {RNA1509_24767, RNA815_8289} | |
| 45. | MligTC455_53580 | 10830 | 225.63 | Mlig455_061858 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.371 Region-specific R2: 2.295 Region-enriched R2: 1.602/0.00040 Regeneration-downregulated BL: -1.692 Regeneration-depleted BL: -1.692 |
4.243 | - | 0.955 | 0.743 | 0.902 | 0.847 | 0.796 | Mlig455_061858 {REF} {Length: 1839} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=32.7]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [Score=77.4, Expect=9e-17]} {RNA1509_2808} {RNA1310_24594} {RNA815_8289} | |
| 46. | MligTC455_19328 | 99 | 2.06 | Mlig455_062531 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.972/0.00232 |
4.195 | 0.950 | 0.890 | 0.766 | - | 0.854 | 0.735 | Mlig455_062531 {REF} {Length: 1929} {NoTransDecoderORF} {RNA1509_36058} {RNA1310_3092} {RNA815_16673} | |
| 47. | MligTC455_40658 | 152 | 3.17 | Mlig455_064614 | Neo: - Age: - |
CLIP2 | 4.173 | - | 0.777 | 0.848 | 0.708 | 0.880 | 0.960 | Mlig455_064614 {REF} {Length: 2460} {Pfam: CAP-Gly domain [PF01302.27, score=60.7]} {Human: ENSG00000106665, CLIP2, CAP-Gly domain containing linker protein 2, [Score=61.6, Expect=2e-09]} {Mouse: ENSMUSG00000063146, Clip2, CAP-GLY domain containing linker protein 2, [Score=62.0, Expect=9e-10]} {Dmel: FBgn0036882, CG9279, [Score=55.1, Expect=9e-08]} {Smed: dd_Smed_v6_12985_0_1, dd_Smed_v6_12985_0_1, [Score=56.2, Expect=2e-08]} {RNA1310_20676} {RNA815_40746} |
| 48. | MligTC455_44390 | 1061 | 22.1 | Mlig455_034325 | Neo: - Age: - Region-specific R2: 4.305 Region-enriched R2: 4.226/0.00000 |
4.165 | 0.854 | 0.880 | 0.777 | 0.704 | 0.950 | - | Mlig455_034325 {REF} {Length: 1082} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [RH, Score=65.1, Expect=2e-13]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [Score=42.0, Expect=9e-06]} {RNA1509_11607} {RNA1310_49918} {RNA815_49783} | |
| 49. | MligTC455_21502 | 36 | 0.75 | Mlig455_018529 | Neo: - Age: - Region-enriched R2: 5.380/0.01311 |
4.161 | 0.892 | - | 0.854 | 0.744 | 0.704 | 0.967 | Mlig455_018529 {REF} {Length: 1004} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=43.7]} {Mouse: ENSMUSG00000032463, Faim, Fas apoptotic inhibitory molecule, [Score=54.7, Expect=2e-09]} {Smed: dd_Smed_v6_4798_0_1, dd_Smed_v6_4798_0_1, [RH, Score=75.1, Expect=7e-18]} {RNA1310_42034} {RNA815_19884} | |
| 50. | MligTC455_53109 | 2974 | 61.95 | Mlig455_067651 | Neo: - Age: - Region-specific R2: 3.788 Region-enriched R2: 2.545/0.00000 Regeneration-downregulated BL: -3.378 Regeneration-depleted BL: -3.378 |
4.149 | - | 0.950 | 0.714 | 0.929 | 0.821 | 0.735 | Mlig455_067651 {REF} {Length: 1328} {RNA1509_11451, RNA1509_20324, RNA1509_53964} {RNA1310_35335, RNA1509_11451, RNA1509_20324, RNA1509_53964} {RNA1509_11451, RNA1509_20324, RNA1509_53964, RNA815_16009.1} | |
| 51. | MligTC455_33280 | 127 | 2.64 | Mlig455_010523 | Neo: - Age: Down-Up-Up |
4.141 | 0.829 | 0.807 | 0.956 | 0.832 | 0.717 | - | Mlig455_010523 {REF} {Length: 587} {RNA1509_48963} {RNA1310_65789} {RNA815_23468} | |
| 52. | MligTC455_46467 | 4047 | 84.32 | Mlig455_009033 | Neo: - Age: Down-Up-Down Region-specific R2: 2.894 Region-enriched R2: 2.264/0.00006 Regeneration-downregulated BL: -2.309 Regeneration-depleted BL: -2.309 |
4.134 | 0.714 | 0.865 | 0.760 | 0.954 | 0.841 | - | Mlig455_009033 {REF} {Length: 1015} {RNA1509_10834, RNA1509_4025, RNA1509_9692} {RNA1310_57568, RNA1509_10834, RNA1509_4025, RNA1509_9692} {RNA1509_10834, RNA1509_4025, RNA1509_9692, RNA815_29793} | |
| 53. | MligTC455_29586 | 237 | 4.95 | Mlig455_024687, Mlig455_024712 | Neo: - Age: - Region-specific R2: 5.384 Region-enriched R2: 6.584/0.00000 |
4.076 | 0.840 | 0.784 | 0.951 | 0.772 | 0.729 | - | Mlig455_024687 {REF} {Length: 1636} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} Mlig455_024712 {REF} {Length: 1612} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} |
|
| 54. | MligTC455_17299 | 538 | 11.21 | Mlig455_036559, Mlig455_057787 | Neo: - Age: - Region-enriched R2: 5.046/0.00000 |
4.024 | 0.786 | 0.798 | 0.773 | 0.715 | - | 0.952 | Mlig455_036559 {REF} {Length: 718} {RNA1509_57277} {RNA1310_52579, RNA1509_57277} {RNA1509_57277, RNA815_26706} Mlig455_057787 {REF} {Length: 741} {RNA1509_57277} {RNA1310_52579} {RNA815_26706} |
|
| 55. | MligTC455_45666 | 652 | 13.58 | Mlig455_013011, Mlig455_013040 | Neo: - Age: Up-Down-Up Region-specific R2: 4.509 Region-enriched R2: 3.140/0.01108 |
3.772 | - | - | 0.951 | 0.921 | 0.951 | 0.949 | Mlig455_013011 {REF} {Length: 1193} {RNA1509_13068} {RNA1310_46610} {RNA815_23273} Mlig455_013040 {REF} {Length: 923} {RNA1509_13068} {RNA1310_46610, RNA1509_13068} {RNA1509_13068, RNA815_23273} |
|
| 56. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 3.635 | - | - | 0.925 | 0.885 | 0.867 | 0.958 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
| 57. | MligTC455_19279 | 4576 | 95.33 | Mlig455_057411 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.654 Region-specific R2: 5.173 Region-enriched R2: 4.585/0.00000 |
CHRNA10 | 3.611 | - | 0.936 | 0.917 | 0.794 | - | 0.964 | Mlig455_057411 {REF} {Length: 1075} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
| 58. | MligTC455_42376 | 61 | 1.27 | Mlig455_069890 | Neo: - Age: - |
3.585 | 0.877 | 0.956 | 0.897 | - | - | 0.855 | Mlig455_069890 {REF} {Length: 630} {TRANSSPLICED} {Pfam: PAN domain [PF00024.28, score=26.1]} {RNA1509_53783} {RNA1310_37190} {RNA815_24434} | |
| 59. | MligTC455_53333 | 44 | 0.91 | Mlig455_019019, Mlig455_055684 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.725/0.03950 |
CHRNA7 | 3.582 | 0.953 | - | 0.836 | 0.841 | - | 0.952 | Mlig455_019019 {REF} {Length: 2615} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=93.9]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=210, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=207, Expect=8e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=206, Expect=3e-58]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=1e-59]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=205, Expect=3e-58]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=221, Expect=3e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=7e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=426, Expect=5e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} Mlig455_055684 {REF} {Length: 2604} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.7]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=211, Expect=9e-60]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=209, Expect=3e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=207, Expect=7e-59]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=9e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=204, Expect=1e-57]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=222, Expect=1e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=6e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=427, Expect=3e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} |
| 60. | MligTC455_32312 | 65 | 1.36 | Mlig455_026936, Mlig455_027086 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.552/0.00000 |
3.577 | 0.959 | 0.902 | 0.893 | - | - | 0.823 | Mlig455_026936 {REF} {Length: 1813} {Pfam: PAN domain [PF00024.28, score=22.0]} {RNA1310_30037.2} {RNA815_37290} Mlig455_027086 {REF} {Length: 7697} {Pfam: PAN domain [PF00024.28, score=21.9]} {RNA1509_4722} {RNA1310_655.1} {RNA815_786} |
|
| 61. | MligTC455_48521 | 56 | 1.17 | Mlig455_004444 | Neo: - Age: - |
3.576 | - | 0.947 | 0.856 | 0.813 | - | 0.960 | Mlig455_004444 {REF} {Length: 3968} {Pfam: GDNF/GAS1 domain [PF02351.18, score=19.4]} {Smed: dd_Smed_v6_19517_0_1, dd_Smed_v6_19517_0_1, [RH, Score=111, Expect=3e-25]} {RNA1509_50708} {RNA1310_13399} {RNA815_27009} | |
| 62. | MligTC455_49307 | 122 | 2.55 | Mlig455_055230 | Neo: - Age: - Region-enriched R2: 4.447/0.04819 |
ZAN | 3.572 | 0.963 | 0.783 | 0.939 | - | - | 0.887 | Mlig455_055230 {REF} {Length: 2947} {Pfam: Glycine rich protein [PF12810.9, score=28.6]} {Human: ENSG00000146839, ZAN, zonadhesin (gene/pseudogene), [Score=79.7, Expect=1e-14]} {Mouse: ENSMUSG00000079173, Zan, zonadhesin, [Score=80.1, Expect=7e-15]} {RNA1310_18897} {RNA815_40026} |
| 63. | MligTC455_16908 | 161 | 3.35 | Mlig455_046916 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.397 Region-enriched R2: 2.938/0.02849 |
SLC17A6 | 3.564 | 0.964 | 0.785 | - | 0.887 | - | 0.928 | Mlig455_046916 {REF} {Length: 3198} {Pfam: Major Facilitator Superfamily [PF07690.18, score=172.0]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=19.6]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=548, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=542, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=536, Expect=0.0]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=551, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=547, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=543, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=482, Expect=6e-163]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=479, Expect=7e-163]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=591, Expect=0.0]} {RNA1509_38152} {RNA1310_23072, RNA1509_38152} {RNA1509_38152, RNA815_14894} |
| 64. | MligTC455_25382 | 4668 | 97.26 | Mlig455_000103, Mlig455_063773 | Neo: - Age: - Region-specific R2: 3.508 Region-enriched R2: 3.123/0.00000 |
3.548 | - | 0.958 | 0.784 | 0.896 | 0.910 | - | Mlig455_000103 {REF} {Length: 990} {RNA1509_36813} {RNA1310_39295, RNA1509_36813} {RNA1509_36813, RNA815_13177} Mlig455_063773 {REF} {Length: 890} {RNA1509_6028} {RNA1310_39295} {RNA815_13177} |
|
| 65. | MligTC455_21755 | 70 | 1.47 | Mlig455_021213 | Neo: - Age: - |
3.541 | 0.951 | 0.892 | 0.771 | - | - | 0.927 | Mlig455_021213 {REF} {Length: 4215} {Pfam: F5/8 type C domain [PF00754.27, score=55.5]} {RNA1509_2515} {RNA1310_33166} {RNA815_14716} | |
| 66. | MligTC455_16416 | 290 | 6.04 | Mlig455_000468 | Neo: - Age: - Region-enriched R2: 2.225/0.04782 |
ROR1 | 3.54 | 0.886 | 0.899 | 0.800 | - | - | 0.955 | Mlig455_000468 {REF} {Length: 2686} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=208.1]; Protein kinase domain [PF00069.27, score=77.3]; Kringle domain [PF00051.20, score=19.4]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [Score=300, Expect=1e-89]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [Score=295, Expect=2e-87]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [Score=281, Expect=2e-82]} {Dmel: FBgn0010407, Ror, [Score=259, Expect=2e-76]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=217, Expect=2e-60]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [Score=328, Expect=1e-100]} {RNA1509_35395} {RNA1310_13558} {RNA815_27446} |
| 67. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 3.537 | - | - | 0.824 | 0.888 | 0.867 | 0.958 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
| 68. | MligTC455_16739 | 628 | 13.08 | Mlig455_040111 | Neo: - Age: logFC(26M/2M)=-0.328 Region-enriched R2: 3.456/0.01732 Regeneration-downregulated R5: -4.251 Regeneration-depleted R5: -4.251 |
PCSK1 | 3.535 | - | - | 0.854 | 0.901 | 0.955 | 0.825 | Mlig455_040111 {REF} {Length: 2929} {Pfam: Subtilase family [PF00082.24, score=160.6]; Proprotein convertase P-domain [PF01483.22, score=87.0]; Peptidase S8 pro-domain [PF16470.7, score=50.0]} {Human: ENSG00000175426, PCSK1, proprotein convertase subtilisin/kexin type 1, [RH, Score=550, Expect=0.0]} {Mouse: ENSMUSG00000021587, Pcsk1, proprotein convertase subtilisin/kexin type 1, [RH, Score=550, Expect=0.0]} {Dmel: FBgn0004598, Fur2, Furin 2, [Score=483, Expect=1e-152]} {Celegans: WBGene00002232, kpc-1, Furin-like protease kpc-1, [Score=468, Expect=3e-156]} {Smed: dd_Smed_v6_8406_0_1, dd_Smed_v6_8406_0_1, [RH, Score=474, Expect=2e-159]} {RNA1509_20395} {RNA1310_6257} {RNA815_2270.1} |
| 69. | MligTC455_41106 | 42 | 0.88 | Mlig455_010275 | Neo: - Age: - Region-enriched R2: 5.386/0.03242 |
CALM1 | 3.531 | 0.973 | - | 0.829 | 0.876 | 0.853 | - | Mlig455_010275 {REF} {Length: 1557} {Pfam: EF hand [PF00036.34, score=32.5]; EF-hand domain pair [PF13499.8, score=30.4]; EF-hand domain [PF13405.8, score=29.3]} {Human: ENSG00000198668, CALM1, calmodulin 1, [Score=67.0, Expect=4e-14]; ENSG00000160014, CALM3, calmodulin 3, [Score=67.0, Expect=4e-14]; ENSG00000143933, CALM2, calmodulin 2, [Score=67.0, Expect=4e-14]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=67.0, Expect=3e-14]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=67.0, Expect=3e-14]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=67.0, Expect=3e-14]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.9, Expect=5e-13]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=66.2, Expect=4e-14]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=66.6, Expect=3e-14]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=66.6, Expect=2e-14]} {RNA1310_51265} |
| 70. | MligTC455_33832 | 112 | 2.34 | Mlig455_029411 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.300/0.00016 |
GLRA3 | 3.53 | 0.843 | - | 0.895 | 0.835 | - | 0.957 | Mlig455_029411 {REF} {Length: 3686} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=3e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=7e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=1e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_35433} |
| 71. | MligTC455_35773 | 89 | 1.86 | Mlig455_064449, Mlig455_064456 | Neo: - Age: - Region-enriched R2: 5.198/0.00725 |
NANP | 3.528 | 0.923 | 0.954 | 0.872 | - | 0.779 | - | Mlig455_064449 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_53432.2} Mlig455_064456 {REF} {Length: 3122} {Pfam: Haloacid dehalogenase-like hydrolase [PF13419.8, score=56.3]; haloacid dehalogenase-like hydrolase [PF00702.28, score=55.3]; HAD-hyrolase-like [PF13242.8, score=44.6]} {Human: ENSG00000170191, NANP, N-acetylneuraminic acid phosphatase, [RH, Score=47.4, Expect=8e-06]} {Mouse: ENSMUSG00000053916, Nanp, N-acetylneuraminic acid phosphatase, [RH, Score=48.5, Expect=2e-06]} {Celegans: WBGene00018465, F45E1.4, [RH, Score=147, Expect=4e-43]} {Smed: dd_Smed_v6_2813_0_3, dd_Smed_v6_2813_0_3, [Score=174, Expect=2e-50]} {RNA1310_59243} {RNA815_62364} |
| 72. | MligTC455_21801 | 58 | 1.22 | Mlig455_015442, Mlig455_032138 | Neo: - Age: - |
NPY1R | 3.527 | 0.933 | 0.950 | - | 0.877 | 0.767 | - | Mlig455_015442 {REF} {Length: 2461} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=130.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=26.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.9]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=128, Expect=5e-32]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=2e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=140, Expect=4e-36]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=120, Expect=1e-29]} {Smed: dd_Smed_v6_25204_0_1, dd_Smed_v6_25204_0_1, [Score=208, Expect=2e-61]} {RNA1310_49156} {RNA815_43783} Mlig455_032138 {REF} {Length: 2633} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=129.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.6]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=126, Expect=2e-31]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=4e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=136, Expect=1e-34]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_25934_0_1, dd_Smed_v6_25934_0_1, [Score=207, Expect=5e-61]} {RNA1310_49156} {RNA815_43783} |
| 73. | MligTC455_17802 | 4269 | 88.94 | Mlig455_014107, Mlig455_014119 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.293 Region-enriched R2: 4.660/0.00000 |
3.524 | - | 0.974 | 0.735 | 0.879 | 0.936 | - | Mlig455_014107 {REF} {Length: 768} {RNA1509_50290, RNA1509_8001} {RNA1310_50688, RNA1509_50290, RNA1509_8001} {RNA1509_50290, RNA1509_8001, RNA815_23571} Mlig455_014119 {REF} {Length: 789} {RNA1509_50290} {RNA1310_50688} {RNA815_23571} |
|
| 74. | MligTC455_17803 | 2158 | 44.95 | Mlig455_014128 | Neo: - Age: - Region-specific R2: 5.111 Region-enriched R2: 4.751/0.00000 |
3.522 | - | 0.973 | 0.734 | 0.876 | 0.939 | - | Mlig455_014128 {REF} {Length: 974} {RNA1509_50290} {RNA1310_50688} {RNA815_23571} | |
| 75. | MligTC455_41036 | 281 | 5.86 | Mlig455_057198 | Neo: - Age: - Region-specific R2: 5.284 Region-enriched R2: 4.243/0.00075 |
3.511 | - | 0.858 | 0.955 | 0.769 | - | 0.929 | Mlig455_057198 {REF} {Length: 538} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.9]} {RNA1509_42071} {RNA1310_74103, RNA1509_42071} {RNA1509_42071, RNA815_38377} | |
| 76. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 3.504 | 0.975 | - | - | 0.760 | 0.872 | 0.897 | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
| 77. | MligTC455_36194 | 30 | 0.61 | Mlig455_064360, Mlig455_064382 | Neo: - Age: - |
B3GNT4 | 3.5 | - | 0.955 | 0.871 | - | 0.705 | 0.969 | Mlig455_064360 {REF} {Length: 3119} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=3e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} Mlig455_064382 {REF} {Length: 3084} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.4, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=92.0, Expect=9e-20]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} |
| 78. | MligTC455_40852 | 128 | 2.66 | Mlig455_042301 | Neo: - Age: Up-Up-Down, logFC(26M/2M)=0.671 Region-enriched R2: 6.158/0.00357 |
PKDREJ | 3.497 | 0.968 | 0.862 | 0.757 | - | - | 0.910 | Mlig455_042301 {REF} {Length: 11184} {Pfam: Polycystin cation channel [PF08016.14, score=273.5]; PKD domain [PF00801.22, score=86.2]; PLAT/LH2 domain [PF01477.25, score=67.1]; REJ domain [PF02010.17, score=66.8]; PKD domain [PF18911.2, score=62.3]; Ion transport protein [PF00520.33, score=45.4]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=283, Expect=2e-75]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=273, Expect=2e-72]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=158, Expect=3e-38]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=254, Expect=4e-67]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=514, Expect=2e-146]} {RNA1509_8046} {RNA1310_93, RNA1509_8046} {RNA1509_8046, RNA815_1216} |
| 79. | MligTC455_14856 | 14 | 0.29 | Mlig455_023184 | Neo: - Age: - |
ANGPTL7 | 3.494 | - | - | 0.906 | 0.911 | 0.726 | 0.951 | Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1} |
| 80. | MligTC455_19275 | 407 | 8.47 | Mlig455_037548 | Neo: - Age: logFC(26M/2M)=0.488 Region-enriched R2: 3.247/0.04164 |
CHRNA10 | 3.485 | 0.953 | 0.900 | - | 0.739 | - | 0.893 | Mlig455_037548 {REF} {Length: 959} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=87.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=96.7, Expect=1e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=97.1, Expect=7e-23]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=95.1, Expect=5e-22]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=1e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=119, Expect=8e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=93.2, Expect=1e-21]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} |
| 81. | MligTC455_43750 | 799 | 16.65 | Mlig455_060601, Mlig455_060642 | Neo: - Age: logFC(26M/2M)=0.548 Region-specific R2: 5.695 Region-enriched R2: 4.415/0.00001 |
3.466 | - | 0.930 | 0.816 | 0.972 | 0.748 | - | Mlig455_060601 {REF} {Length: 722} {RNA1509_23811, RNA1509_48787} {RNA1310_60850, RNA1509_23811, RNA1509_48787} {RNA1509_23811, RNA1509_48787, RNA815_31279} Mlig455_060642 {REF} {Length: 646} {RNA1509_23811} {RNA1310_60850} {RNA815_31279} |
|
| 82. | MligTC455_25072 | 4443 | 92.56 | Mlig455_015899 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.175 Region-enriched R2: 4.389/0.00000 |
PI16 | 3.466 | - | 0.825 | - | 0.856 | 0.832 | 0.953 | Mlig455_015899 {REF} {Length: 2017} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=112, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=5e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.5, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=5e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_5027} {RNA1310_1356.1} {RNA815_4508} |
| 83. | MligTC455_45769 | 79 | 1.65 | Mlig455_018116 | Neo: - Age: - |
3.465 | - | 0.880 | 0.898 | - | 0.716 | 0.971 | Mlig455_018116 {REF} {Length: 3312} {Pfam: NACHT domain [PF05729.14, score=33.6]; AAA ATPase domain [PF13191.8, score=25.1]; AAA domain [PF13401.8, score=19.4]} {Smed: dd_Smed_v6_9074_0_1, dd_Smed_v6_9074_0_1, [Score=138, Expect=2e-33]} {RNA1509_44893} {RNA1310_38241} {RNA815_33748} | |
| 84. | MligTC455_41368 | 369 | 7.68 | Mlig455_007683, Mlig455_020872, Mlig455_020918, Mlig455_020998 | Neo: - Age: - |
3.464 | 0.972 | 0.843 | 0.793 | - | - | 0.856 | Mlig455_007683 {REF} {Length: 1379} {RNA1310_25040.2} {RNA815_12562.1} Mlig455_020872 {REF} {Length: 1217} {RNA1310_25040.2} {RNA815_12562.1} Mlig455_020918 {REF} {Length: 1220} {RNA1310_25040.2} {RNA815_12562.1} Mlig455_020998 {REF} {Length: 1235} {RNA1310_25040.1} {RNA815_12562.1} |
|
| 85. | MligTC455_46009 | 5464 | 113.82 | Mlig455_061251, Mlig455_062639 | Neo: - Age: logFC(26M/2M)=-0.276 Region-specific R2: 2.871 Region-enriched R2: 2.103/0.00001 |
3.461 | 0.743 | 0.968 | - | 0.909 | 0.841 | - | Mlig455_061251 {REF} {Length: 1343} {Smed: dd_Smed_v6_1520_0_1, dd_Smed_v6_1520_0_1, [Score=54.7, Expect=6e-10]} {RNA1509_3086} {RNA1310_72677.2} {RNA815_25863} Mlig455_062639 {REF} {Length: 1176} {Smed: dd_Smed_v6_1520_0_1, dd_Smed_v6_1520_0_1, [Score=54.7, Expect=6e-10]} {RNA1509_3086} {RNA1310_72677.2} {RNA815_25863} |
|
| 86. | MligTC455_46543 | 178 | 3.7 | Mlig455_000344, Mlig455_067946 | Neo: - Age: - Region-specific R2: 6.098 Region-enriched R2: 6.851/0.00000 |
3.459 | 0.958 | - | 0.869 | 0.907 | 0.725 | - | Mlig455_000344 {REF} {Length: 1920} {RNA1310_82457} {RNA815_33120} Mlig455_067946 {REF} {Length: 1217} {RNA1310_99435} |
|
| 87. | MligTC455_48720 | 1367 | 28.48 | Mlig455_017034 | Neo: - Age: - Region-specific R2: 4.593 Region-enriched R2: 3.164/0.00157 |
3.454 | - | 0.954 | 0.761 | 0.875 | 0.864 | - | Mlig455_017034 {REF} {Length: 866} {RNA1509_17554, RNA1509_28146} {RNA1310_40772, RNA1509_28146} {RNA1509_28146, RNA815_29897} | |
| 88. | MligTC455_17701 | 1279 | 26.65 | Mlig455_051483 | Neo: - Age: Down-Up-Up Region-specific R2: 5.592 Region-enriched R2: 6.602/0.00000 |
3.45 | - | 0.959 | 0.916 | 0.812 | - | 0.763 | Mlig455_051483 {REF} {Length: 1833} {RNA1509_14131} {RNA1310_69964.2, RNA1509_14131} {RNA1509_14131, RNA815_35453.1} | |
| 89. | MligTC455_29408 | 45 | 0.94 | Mlig455_038322 | Neo: - Age: - Region-enriched R2: 8.586/0.00762 |
MB | 3.443 | 0.862 | 0.887 | - | - | 0.741 | 0.953 | Mlig455_038322 {REF} {Length: 2059} {Pfam: Globin [PF00042.24, score=57.8]} {Human: ENSG00000198125, MB, myoglobin, [RH, Score=47.8, Expect=5e-07]} {Mouse: ENSMUSG00000018893, Mb, myoglobin, [RH, Score=45.4, Expect=2e-06]} {Celegans: WBGene00008996, glb-14, GLoBin related, [Score=51.6, Expect=4e-08]} {Smed: dd_Smed_v6_15997_0_1, dd_Smed_v6_15997_0_1, [RH, Score=63.5, Expect=1e-12]} {RNA1509_48898} {RNA1310_47695} {RNA815_7096.1} |
| 90. | MligTC455_53579 | 15576 | 324.49 | Mlig455_010515 | Neo: - Age: - Region-enriched R2: 1.446/0.00265 Regeneration-downregulated BL: -1.566 Regeneration-depleted BL: -1.566 |
3.441 | - | 0.953 | - | 0.894 | 0.834 | 0.760 | Mlig455_010515 {REF} {Length: 1448} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=80.3]} {Dmel: FBgn0041707, 7B2, [RH, Score=70.1, Expect=2e-13]} {Celegans: WBGene00011392, sbt-1, Seven B Two (Mammalian 7BT prohormone convertase chaperone) homolog, [RH, Score=67.4, Expect=5e-13]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [RH, Score=119, Expect=7e-32]} {RNA1509_1202, RNA1509_1348, RNA1509_17830} {RNA1310_24594, RNA1509_1202, RNA1509_1348, RNA1509_17830} {RNA1509_1202, RNA1509_1348, RNA1509_17830, RNA815_8289} | |
| 91. | MligTC455_03382 | 210 | 4.37 | Mlig455_057035 | Neo: - Age: - Region-enriched R2: 3.628/0.00113 |
PDE1C | 3.439 | - | 0.820 | 0.907 | - | 0.739 | 0.973 | Mlig455_057035 {REF} {Length: 2458} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=275.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=94.2]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [RH, Score=546, Expect=0.0]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [RH, Score=546, Expect=0.0]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [RH, Score=538, Expect=0.0]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [RH, Score=482, Expect=2e-164]} {Smed: dd_Smed_v6_11039_0_2, dd_Smed_v6_11039_0_2, [RH, Score=613, Expect=0.0]} {RNA1509_46084} {RNA1310_8143.1} {RNA815_6002} |
| 92. | MligTC455_30160 | 55 | 1.15 | Mlig455_035128 | Neo: - Age: - Region-enriched R2: 5.270/0.01686 |
TCF7L1 | 3.388 | 0.956 | - | - | 0.737 | 0.733 | 0.962 | Mlig455_035128 {REF} {Length: 2946} {Pfam: HMG (high mobility group) box [PF00505.21, score=79.2]; HMG-box domain [PF09011.12, score=34.5]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=1e-42]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=158, Expect=7e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=2e-41]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=8e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=158, Expect=9e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=156, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=6e-48]} {RNA1509_46571} {RNA1310_11181} {RNA815_36690} |
| 93. | MligTC455_51478 | 66 | 1.37 | Mlig455_057080 | Neo: - Age: - |
3.378 | - | - | 0.835 | 0.869 | 0.722 | 0.952 | Mlig455_057080 {REF} {Length: 1661} {Pfam: 7tm Chemosensory receptor [PF08395.14, score=33.2]; Trehalose receptor [PF06151.15, score=30.3]} {RNA1310_59684} {RNA815_43381} | |
| 94. | MligTC455_18602 | 116 | 2.42 | Mlig455_003494 | Neo: - Age: - |
KCTD21 | 3.378 | 0.836 | 0.817 | 0.950 | - | - | 0.775 | Mlig455_003494 {REF} {Length: 3275} {Pfam: BTB/POZ domain [PF02214.24, score=65.0]} {Human: ENSG00000188997, KCTD21, potassium channel tetramerization domain containing 21, [Score=88.6, Expect=3e-21]; ENSG00000183783, KCTD8, potassium channel tetramerization domain containing 8, [Score=87.8, Expect=7e-19]} {Mouse: ENSMUSG00000044952, Kctd21, potassium channel tetramerisation domain containing 21, [Score=87.8, Expect=5e-20]; ENSMUSG00000037653, Kctd8, potassium channel tetramerisation domain containing 8, [Score=85.9, Expect=2e-18]} {Dmel: FBgn0038839, Ktl, Kctd12-like, [Score=82.0, Expect=3e-18]} {Celegans: WBGene00014848, VM106R.1, [Score=77.4, Expect=4e-16]} {Smed: dd_Smed_v6_8654_0_1, dd_Smed_v6_8654_0_1, [Score=89.0, Expect=8e-21]} {RNA1310_21779.1} {RNA815_18356} |
| 95. | MligTC455_31104 | 22 | 0.46 | Mlig455_040032, Mlig455_070983 | Neo: - Age: - |
SYT17 | 3.363 | 0.955 | - | 0.748 | - | 0.740 | 0.920 | Mlig455_040032 {REF} {Length: 2712} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} Mlig455_070983 {REF} {Length: 1947} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} |
| 96. | MligTC455_13375 | 48 | 1 | Mlig455_008269 | Neo: - Age: - Region-enriched R2: 6.043/0.00338 |
3.359 | 0.777 | - | 0.815 | 0.816 | - | 0.951 | Mlig455_008269 {REF} {Length: 2598} {RNA1310_27894} {RNA815_60961} | |
| 97. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 3.33 | 0.702 | - | 0.913 | 0.749 | - | 0.966 | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
| 98. | MligTC455_30159 | 107 | 2.22 | Mlig455_008465, Mlig455_009916 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.961/0.00498 |
TCF7L1 | 3.287 | 0.817 | - | - | 0.770 | 0.735 | 0.965 | Mlig455_008465 {REF} {Length: 2454} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.3]; HMG-box domain [PF09011.12, score=34.6]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=7e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=8e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=4e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=4e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=6e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=4e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=2e-48]} {RNA1310_11181} {RNA815_36690} Mlig455_009916 {REF} {Length: 2137} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.4]; HMG-box domain [PF09011.12, score=34.7]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=4e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=2e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=157, Expect=5e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=162, Expect=2e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=4e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=3e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=1e-48]} {RNA1310_11181} {RNA815_36690} |
| 99. | MligTC455_46341 | 243 | 5.06 | Mlig455_052880, Mlig455_052884 | Neo: - Age: - |
3.273 | 0.781 | 0.744 | - | 0.790 | - | 0.958 | Mlig455_052880 {REF} {Length: 1228} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=28.6]; Dpy-30 motif [PF05186.15, score=22.0]; Ankyrin repeats (many copies) [PF13637.8, score=20.9]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [Score=60.5, Expect=6e-10]} {RNA1509_39973} {RNA1310_21889} {RNA815_13094} Mlig455_052884 {REF} {Length: 1926} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=39.4]; Ankyrin repeats (many copies) [PF13637.8, score=27.7]; Ankyrin repeats (many copies) [PF13857.8, score=24.6]; Dpy-30 motif [PF05186.15, score=21.6]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [Score=72.8, Expect=1e-13]} {RNA1509_39973} {RNA1310_21889, RNA1509_39973} {RNA1509_39973, RNA815_13094} |
|
| 100. | MligTC455_42097 | 210 | 4.37 | Mlig455_064897, Mlig455_064901 | Neo: - Age: - Region-enriched R2: 3.777/0.00394 |
KCTD16 | 3.271 | - | 0.841 | 0.961 | 0.747 | - | 0.722 | Mlig455_064897 {REF} {Length: 1965} {Pfam: BTB/POZ domain [PF02214.24, score=51.4]} {Human: ENSG00000183775, KCTD16, potassium channel tetramerization domain containing 16, [RH, Score=176, Expect=6e-51]} {Mouse: ENSMUSG00000051401, Kctd16, potassium channel tetramerisation domain containing 16, [RH, Score=177, Expect=1e-51]; ENSMUSG00000041633, Kctd12b, potassium channel tetramerisation domain containing 12b, [RH, Score=169, Expect=1e-49]} {Dmel: FBgn0038839, Ktl, Kctd12-like, [RH, Score=258, Expect=1e-85]} {Celegans: WBGene00014848, VM106R.1, [RH, Score=184, Expect=1e-55]} {Smed: dd_Smed_v6_12440_0_1, dd_Smed_v6_12440_0_1, [RH, Score=248, Expect=9e-82]} {RNA1310_28657.2} {RNA815_14650} Mlig455_064901 {REF} {Length: 1674} {Pfam: BTB/POZ domain [PF02214.24, score=51.3]} {Human: ENSG00000183775, KCTD16, potassium channel tetramerization domain containing 16, [RH, Score=176, Expect=1e-50]} {Mouse: ENSMUSG00000051401, Kctd16, potassium channel tetramerisation domain containing 16, [RH, Score=177, Expect=2e-51]} {Dmel: FBgn0038839, Ktl, Kctd12-like, [RH, Score=258, Expect=3e-85]} {Celegans: WBGene00014848, VM106R.1, [RH, Score=183, Expect=3e-55]} {Smed: dd_Smed_v6_12440_0_1, dd_Smed_v6_12440_0_1, [RH, Score=247, Expect=2e-81]} {RNA1310_28657.2} {RNA815_14650} |
There are 145 more genes with r >= 0.95